Pulsed Shortwave Therapy Adjunct Pain and Recovery in Total Knee Replacement

Total Knee Arthroplasty Clinical Trial

Official title: Double Blind Placebo-controlled Clinical Trial to Assess Pulsed Shortwave Therapy as an Adjunct Pain Therapy & Knee Recovery for Total Knee Arthroplasty

Status Recruiting

Clinical Trial Summary

This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following total knee replacement. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.

Clinical Trial Description

Despite the recent advances in the understanding of pain mechanisms and the introduction of new drugs and new techniques in the postoperative management, pain after total knee arthroplasty (TKA) is still an unresolved issue. It affects the quality of life and rehabilitation of an important percentage of patients undergoing TKA. A recent study looked at the percentage of patients with chronic knee pain after knee replacement at a minimum of one year following surgery in 272 patients, 107 patients (nearly 40%) reported that they still had persistent pain at one-plus year following surgery. Central sensitization is now well established as an integral factor in many chronic pain states, including the commonly occurring knee and back pain. Many patients undergoing TKA are likely to have a significant degree of Central Sensitization, therefore the likely hood of high pain levels postoperative and persistent long standing pain after TKA is increased in this patient population.

Pulsed shortwave therapy negates central sensitization by imputing new ;

Related Conditions & MeSH terms

• Total Knee Arthroplasty

• NCT number: NCT03395444
• Study type: Interventional
• Source: BioElectronics Corporation
• Contact: Mahmoud Maassarani, Ph.D
• Phone: 96179156547
• Email: M.masarani@outlook.fr
• Status: Recruiting
• Phase: N/A
• Start date: December 15, 2017
• Completion date: March 15, 2019